Literature DB >> 9610724

Human Trop-2 is a tumor-associated calcium signal transducer.

E Ripani1, A Sacchetti, D Corda, S Alberti.   

Abstract

Trop-2/EGP-1/GA733-1 is a recently identified cell surface glycoprotein highly expressed by human carcinomas. The cytoplasmic tail of Trop-2 possesses potential serine and tyrosine phosphorylation sites and a phosphatidyl-inositol binding consensus sequence. Thus, we investigated whether Trop-2 might be a functional signaling molecule. Using the fluorescent probe Fura-2, we assayed the cytoplasmic calcium levels in human cancer cells stimulated with anti-Trop-2 or control antibodies. Three anti-Trop-2 MAbs, Rs7-7G11, MOv16 and 162-46.2 specifically induced a transient intracellular calcium level increment in up to 40% of the experiments performed. Polyclonal antisera recognizing recombinant Trop-2 molecules possessed a much lower stimulation efficiency. The average latency of antibody-induced Ca2+ rise for OvCa-432 cells was 64+/-26 sec. Internal Ca2+ concentrations reached peaks of 190+/-24 nM vs. basal levels of 61+/-4 nM and returned to baseline within 193+/-37 sec. Similar values were obtained in MCF-7 cells. For comparison, stimulation of P2-purinergic receptors on MCF-7 and OvCa-432 cells induced a Ca2+ rise in most cases, leading to average internal Ca2+ concentrations of 297+/-41 and 391+/-39 nM, respectively. Our findings show that Trop-2 transduces an intracellular calcium signal, are consistent with the hypothesis that it acts as a cell surface receptor and support a search for a physiological ligand.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610724     DOI: 10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  68 in total

1.  Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.

Authors:  Xi Wang; Min Long; Ke Dong; Fang Lin; Yuanyuan Weng; Yongri Ouyang; Li Liu; Junxia Wei; Xi Chen; Ting He; Hui-Zhong Zhang
Journal:  Cancer Biol Ther       Date:  2013-09-04       Impact factor: 4.742

2.  A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.

Authors:  Marian Grade; Amanda B Hummon; Jordi Camps; Georg Emons; Melanie Spitzner; Jochen Gaedcke; Patrick Hoermann; Reinhard Ebner; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Tim Beissbarth; Natasha J Caplen; Thomas Ried
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

3.  Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.

Authors:  Hiromi Kobayashi; Yuko Minami; Yoichi Anami; Yuzuru Kondou; Tatsuo Iijima; Junko Kano; Yukio Morishita; Koji Tsuta; Shinichiro Hayashi; Masayuki Noguchi
Journal:  Virchows Arch       Date:  2010-05-16       Impact factor: 4.064

4.  Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C α/δ (PKCα/δ) enhances cell motility.

Authors:  Yugo Mori; Kaoru Akita; Kazuki Ojima; Shungo Iwamoto; Tomoko Yamashita; Eiichi Morii; Hiroshi Nakada
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

5.  Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.

Authors:  Marco Trerotola; Danielle L Jernigan; Qin Liu; Javed Siddiqui; Alessandro Fatatis; Lucia R Languino
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

6.  Prognostic value of TROP2 in human nasopharyngeal carcinoma.

Authors:  Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Duo-Jiao Yu; Yan Zhao; Lin Zhu; Ying-Yuan Guo; Ying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

8.  Identification and characterization of a novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy.

Authors:  Preeti Paliwal; Jaya Gupta; Radhika Tandon; Namrata Sharma; Jeewan S Titiyal; Seema Kashyap; Seema Sen; Punit Kaur; Divya Dube; Arundhati Sharma; Rasik B Vajpayee
Journal:  Mol Vis       Date:  2010-04-28       Impact factor: 2.367

9.  A novel TACSTD2 mutation identified in two Chinese brothers with gelatinous drop-like corneal dystrophy.

Authors:  Yang Jing; Chun Liu; Liya Wang
Journal:  Mol Vis       Date:  2009-08-14       Impact factor: 2.367

10.  Two novel mutations identified in two Chinese gelatinous drop-like corneal dystrophy families.

Authors:  Bei Zhang; Yu-Feng Yao; Ping Zhou
Journal:  Mol Vis       Date:  2007-06-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.